SCHEMBL4788444

SCHEMBL4788444

C[C@@H](NC(=O)C=CC(=O)O)c1ccc(F)cc1F

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ GAA P10253 1/20 0.45
▸ TAAR1 Q96RJ0 1/20 0.43
▸ GPR139 Q6DWJ6 2/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CES2 O00748 1/20 0.40
▸ CES1 P23141 1/20 0.40
▸ PPARG P37231 1/20 0.39
▸ SLC6A2 P23975 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31187732 0.79 L3MBTL1 (0.48) GAAGPR139KMT2ACES2CES1
SCHEMBL31359082 0.79 L3MBTL1 (0.48) GAAGPR139KMT2ACES2CES1
SCHEMBL26896061 0.77 CES2 (0.45) ALDH1A1CYP2C19GPR139CYP1A2KMT2A
SCHEMBL8300134 0.76 CES2 (0.44) ALDH1A1GPR139KMT2ACES2CES1
SCHEMBL23123653 0.74 GPR139 (0.49) ALDH1A1CYP2C19GPR139CYP3A4KMT2A
SCHEMBL29757886 0.74 GPR139 (0.49) ALDH1A1CYP2C19GPR139CYP3A4KMT2A
SCHEMBL23123650 0.74 GPR139 (0.49) ALDH1A1CYP2C19GPR139CYP3A4KMT2A
SCHEMBL5644652 0.71 NPC1 (0.51) ALDH1A1GAAGPR139KMT2AMEN1
SCHEMBL17041588 0.71 TRPA1 (0.44) GPR139KMT2ACES2CES1PPARG
SCHEMBL6895432 0.71 ALDH1A1 (1.00) ALDH1A1CYP2C19GAACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008124518-A1 OXO-DIHYDROISOINDOLE SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-10-16 — — WO disclosed
Send feedback